Robert J Brager, MD | |
7485 Right Flank Rd, Suite 210, Mechanicsville, VA 23116-3839 | |
(804) 484-3700 | |
(804) 320-6462 |
Full Name | Robert J Brager |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 34 Years |
Location | 7485 Right Flank Rd, Mechanicsville, Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568460087 | NPI | - | NPPES |
6502296 | Medicaid | VA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 0101054187 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Bon Secours Memorial Regional Medical Center | Mechanicsville, VA | Hospital |
Bon Secours St Marys Hospital | Richmond, VA | Hospital |
Henrico Doctors' Hospital | Richmond, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Virginia Ear Nose And Throat Associates Pc | 6901794999 | 31 |
News Archive
Scientists at the Medical College of Wisconsin Cancer Center and an international team of collaborators have generated mice with an improved hormone profile that supports growth and metastatic spread of implanted human breast tumors.
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.
EpiCept Corporation today announced operating and financial results for the three and nine months ended September 30, 2011, and provided an update with respect to the Company's key business initiatives.
Endoscopic ultrasonography (EUS) is a highly sensitive diagnostic method for the detection of small pancreatic carcinomas. Recently, there have been some reports describing the utility of contrast-enhanced harmonic EUS (CEH-EUS) which uses sonographic contrast agent for differentiation of a pancreatic mass.
Undertaking thrombolysis on the basis of magnetic resonance imaging findings in patients with stroke of unknown onset time may double their chances for a good outcome, say researchers.
› Verified 4 days ago
Entity Name | Virginia Ear Nose & Throat Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356325757 PECOS PAC ID: 6901794999 Enrollment ID: O20040310000578 |
News Archive
Scientists at the Medical College of Wisconsin Cancer Center and an international team of collaborators have generated mice with an improved hormone profile that supports growth and metastatic spread of implanted human breast tumors.
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.
EpiCept Corporation today announced operating and financial results for the three and nine months ended September 30, 2011, and provided an update with respect to the Company's key business initiatives.
Endoscopic ultrasonography (EUS) is a highly sensitive diagnostic method for the detection of small pancreatic carcinomas. Recently, there have been some reports describing the utility of contrast-enhanced harmonic EUS (CEH-EUS) which uses sonographic contrast agent for differentiation of a pancreatic mass.
Undertaking thrombolysis on the basis of magnetic resonance imaging findings in patients with stroke of unknown onset time may double their chances for a good outcome, say researchers.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Robert J Brager, MD 7485 Right Flank Rd, Suite 210, Mechanicsville, VA 23116-3839 Ph: (804) 484-3700 | Robert J Brager, MD 7485 Right Flank Rd, Suite 210, Mechanicsville, VA 23116-3839 Ph: (804) 484-3700 |
News Archive
Scientists at the Medical College of Wisconsin Cancer Center and an international team of collaborators have generated mice with an improved hormone profile that supports growth and metastatic spread of implanted human breast tumors.
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.
EpiCept Corporation today announced operating and financial results for the three and nine months ended September 30, 2011, and provided an update with respect to the Company's key business initiatives.
Endoscopic ultrasonography (EUS) is a highly sensitive diagnostic method for the detection of small pancreatic carcinomas. Recently, there have been some reports describing the utility of contrast-enhanced harmonic EUS (CEH-EUS) which uses sonographic contrast agent for differentiation of a pancreatic mass.
Undertaking thrombolysis on the basis of magnetic resonance imaging findings in patients with stroke of unknown onset time may double their chances for a good outcome, say researchers.
› Verified 4 days ago
Dr. David Scott Cross, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 8409 North Run Medical Drive, Mechanicsville, VA 23116 Phone: 804-569-6240 Fax: 804-569-6244 | |
Mari Miyamoto Hayashi, PHD/CCC-SLP Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 8409 N Run Medical Dr, Mechanicsville, VA 23116 Phone: 804-569-6240 Fax: 804-569-6244 |